Exploring Undiscovered Gems in Asia This September 2025

As global markets adapt to changing monetary policies and the AI boom, Asian economies face both challenges and opportunities. Investors are focusing on small-cap stocks, particularly in China and Japan. The article highlights ten promising companies with strong fundamentals, including Changzhou Langbo Sealing Technologies, Wuxi Zhenhua Auto Parts, and Bide Pharmatech, showcasing their financial performance and growth potential. These companies are seen as "undiscovered gems" in the region, appealing to investors seeking growth in dynamic markets.

Eight biopharmaceutical and CXO companies on the Sci-Tech Innovation Board gathered for a performance briefing, breaking through key technological bottlenecks became the focus of interaction

On September 15th, eight companies in the biopharmaceutical and CXO industries on the STAR Market held a performance briefing, using an online interactive Q&A format to address investor concerns and discuss industry ecology and development trends. Participating companies such as Bide and CABIO shared their R&D progress and global market layout, demonstrating confidence in their development for the second half of the year

Some shareholders of Bide Pharmaceuticals plan to reduce their holdings by no more than 1%

According to the announcement released by Bide, due to the liquidity needs of the shareholders, shareholders Li Yijing, Chen Jun, Li Li, Du Juan, Li Aifei, Geng Yong, and Jiang Yamei plan to reduce their holdings of the company's shares through centralized bidding within three months after the disclosure of this reduction plan, with the number of shares to be reduced not exceeding 1% of the company's total share capital

Bide Pharmaceuticals shareholders Zhoushan Xinxie, Ningbo Landan, and their concerted parties plan to reduce their holdings by no more than 2.86% of shares

Shareholders of Bide, Zhoushan Xinxie, Ningbo Landan, and their concerted action person Wu Bo plan to reduce their holdings by no more than 2.86%. Zhoushan Xinxie and Ningbo Landan each intend to reduce their holdings by no more than 908,800 shares through block trades, while Wu Bo plans to reduce his holdings by no more than 785,800 shares through centralized bidding

A-share innovative drug concept stocks rose again, with Chemexpress, HitGen, and Medicilon increasing by over 10%, while Bide and WuXi AppTec also followed suit